Orchestrate repeatable design-make-test-learn ways of working by defining scientific questions, decision criteria, feedback loops, escalation paths, knowledge-capture needs, and fit-for-purpose success measures with program teams that can be built into reusable platforms and production-grade capabilities in partnership with your In Silico Discovery teammates. By connecting portfolio-embedded CD3 scientists with medicinal chemistry, experimental partners, automation teams, CI, D3S, ISB, and CADD Technical Development, you will help create faster learning cycles, better compound designs, stronger evidence-based decisions, broader reuse of validated capabilities, and more consistent delivery of differentiated candidates for patients.